3-ft has been researched along with fluorouracil in 9 studies
| Studies (3-ft) | Trials (3-ft) | Recent Studies (post-2010) (3-ft) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 16 | 1 | 0 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | 3-ft (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S; Marunaka, T; Yamawaki, I; Yasumoto, M | 1 |
| Hashimoto, S; Ueda, S; Yamashita, J; Yasumoto, M | 1 |
| Emi, Y; Kohnoe, S; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M | 1 |
| Anai, H; Emi, Y; Kohnoe, S; Maehara, Y; Sakaguchi, Y; Sugimachi, K | 1 |
| Arima, S; Futami, K; Shimura, H; Toriya, H | 1 |
| Anai, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
| Hirose, S; Iwamoto, M; Yoshida, S | 1 |
| Marunaka, T; Minami, Y; Umeno, Y | 1 |
| Kasahara, N; Kudo, H; Mizuno, M; Mori, T; Nagasawa, H; Sakamoto, S; Sugiura, Y; Suzuki, S | 1 |
9 other study(ies) available for 3-ft and fluorouracil
| Article | Year |
|---|---|
Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Fluorouracil; Lethal Dose 50; Mice; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma, Yoshida; Tegafur | 1978 |
Studies on tetrahydrofuranyl-5-fluorouracils. 2. NMR studies of 1-(tetrahydro-2-furanyl)-, 3-(tetrahydro-2-furanyl)-, and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracils.
Topics: Fluorouracil; Magnetic Resonance Spectroscopy; Nucleic Acid Conformation; Structure-Activity Relationship; Tegafur | 1979 |
Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Phosphorylation; Sarcoma 180; Tegafur; Tumor Cells, Cultured | 1992 |
A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer.
Topics: Antibiotics, Antineoplastic; Biotransformation; Depression, Chemical; Female; Fluorouracil; Humans; Injections, Intravenous; Male; Middle Aged; Proteoglycans; Stomach Neoplasms; Tegafur | 1991 |
The uptake of anticancer drugs by tumor tissues and lymph node and the effectiveness of postoperative adjuvant chemotherapy on survival time.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Lymph Nodes; Prognosis; Stomach Neoplasms; Tegafur; Time Factors | 1989 |
Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kidney; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Subrenal Capsule Assay; Tegafur; Uracil | 1988 |
Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Fluorouracil; Humans; Spectrometry, Fluorescence; Tegafur; Time Factors | 1984 |
Quantitative determination of 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione and its metabolites in visceral tissues by high-performance liquid chromatography and gas chromatography-mass fragmentography.
Topics: Animals; Chromatography, High Pressure Liquid; Fluorouracil; Gas Chromatography-Mass Spectrometry; Neoplasms; Rats; Tegafur | 1980 |
Suppression of mammary tumors by oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil in SHN virgin mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Female; Fluorouracil; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Organ Size; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1993 |